Serial Number | 79239267 |
Word Mark | OXURION |
Filing Date | Monday, June 25, 2018 |
Status | 700 - REGISTERED |
Status Date | Tuesday, June 11, 2019 |
Registration Number | 5772180 |
Registration Date | Tuesday, June 11, 2019 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 26, 2019 |
Goods and Services | Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops |
Goods and Services | Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services |
Goods and Services | Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 24, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 24, 2018 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 24, 2018 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Oxurion NV |
Party Type | 30 - Original Registrant |
Legal Entity Type | 32 - NOT AVAILABLE |
Address | BE |
Party Name | ThromboGenics |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 32 - NOT AVAILABLE |
Address | BE |
Party Name | ThromboGenics |
Party Type | 10 - Original Applicant |
Legal Entity Type | 32 - NOT AVAILABLE |
Address | BE |
Event Date | Event Description |
Thursday, August 23, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, August 24, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 28, 2018 | APPLICATION FILING RECEIPT MAILED |
Saturday, October 13, 2018 | ASSIGNED TO EXAMINER |
Saturday, October 13, 2018 | NON-FINAL ACTION WRITTEN |
Sunday, October 14, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, October 25, 2018 | REFUSAL PROCESSED BY MPU |
Thursday, October 25, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, November 9, 2018 | REFUSAL PROCESSED BY IB |
Wednesday, January 30, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, January 30, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, January 30, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, January 30, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, January 30, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, March 6, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, March 6, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, March 6, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Saturday, March 23, 2019 | NOTIFICATION PROCESSED BY IB |
Tuesday, March 26, 2019 | PUBLISHED FOR OPPOSITION |
Tuesday, March 26, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 11, 2019 | REGISTERED-PRINCIPAL REGISTER |
Thursday, June 13, 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Saturday, February 2, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, February 15, 2019 | ASSIGNED TO LIE |
Wednesday, September 11, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Saturday, September 21, 2019 | FINAL DISPOSITION PROCESSED |
Saturday, September 21, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
Saturday, October 12, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Tuesday, June 11, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |